At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 116 enrolled
Drug / intervention
Influenza Virus Vaccine (2006-2007 Fluzone® vaccine) +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2006-2007 Formulation)
In Brief
A Phase 4 clinical trial evaluating Influenza Virus Vaccine (2006-2007 Fluzone® vaccine) for Influenza. Completed, enrolled 116 participants across 1 site.
Detailed Summary
To submit remaining available sera to Center for Biologics Evaluation and Research (CBER) for further analysis by the Food and Drug Administration (FDA), the Center for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to support selection and recommendation of antigen strains for subsequent influenza vaccines.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2006
First PostedOct 2006
Primary CompletionApr 2008
Study CompletionSep 2008
TodayJul 2026
First PostedOct 19, 2006
Enrollment StartOct 1, 2006
Primary CompletionApr 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 19.7 years ago
Interventions
Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)biological
Influenza vaccine
Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)biological
Influenza vaccine